The role of m6A RNA methylation in cancer metabolism

Y An, H Duan - Molecular cancer, 2022 - Springer
Metabolic reprogramming is one of the main characteristics of malignant tumors, which is
due to the flexible changes of cell metabolism that can meet the needs of cell growth and …

LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer

YT Tan, JF Lin, T Li, JJ Li, RH Xu… - Cancer …, 2021 - Wiley Online Library
Altered metabolism is a hallmark of cancer, and the reprogramming of energy metabolism
has historically been considered a general phenomenon of tumors. It is well recognized that …

The role of ubiquitination and deubiquitination in cancer metabolism

T Sun, Z Liu, Q Yang - Molecular cancer, 2020 - Springer
Metabolic reprogramming, including enhanced biosynthesis of macromolecules, altered
energy metabolism, and maintenance of redox homeostasis, is considered a hallmark of …

F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer

J Hong, F Guo, SY Lu, C Shen, D Ma, X Zhang, Y Xie… - Gut, 2021 - gut.bmj.com
Objective Microbiota disorder promotes chronic inflammation and carcinogenesis. High
glycolysis is associated with poor prognosis in patients with colorectal cancer (CRC) …

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities

T Ge, X Gu, R Jia, S Ge, P Chai… - Cancer …, 2022 - Wiley Online Library
Reversible, spatial, and temporal regulation of metabolic reprogramming and epigenetic
homeostasis are prominent hallmarks of carcinogenesis. Cancer cells reprogram their …

LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC

X Qian, J Yang, Q Qiu, X Li, C Jiang, J Li… - Journal of hematology & …, 2021 - Springer
Abstract Background Long non-coding RNAs (lncRNAs) are important epigenetic regulators,
which play critical roles in diverse physiological and pathological processes. However, the …

Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer

X Chen, R Luo, Y Zhang, S Ye, X Zeng, J Liu… - Nature …, 2022 - nature.com
Aromatase inhibition is an efficient endocrine therapy to block ectopic estrogen production
for postmenopausal estrogen receptor (ER)-positive breast cancer patients, but many …

lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling

X Lin, S Zhuang, X Chen, J Du, L Zhong, J Ding… - Molecular Therapy, 2022 - cell.com
Long non-coding RNAs (lncRNAs) play critical roles in tumorigenesis and progression of
colorectal cancer (CRC). However, functions of most lncRNAs in CRC and their molecular …

NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer

Z Jing, Q Liu, X He, Z Jia, Z Xu, B Yang… - Journal of Experimental & …, 2022 - Springer
Background NCAPD3 is one of the three non-SMC subunits of condensin II complex, which
plays an important role in the chromosome condensation and segregation during mitosis …

Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression

S Wang, L Zhou, N Ji, C Sun, L Sun, J Sun, Y Du… - Drug Resistance …, 2023 - Elsevier
Abstract Acylphosphatase 1 (ACYP1), a protein located in the mammalian cell cytoplasm,
has been shown to be associated with tumor initiation and progression by functioning as a …